Archive for February 7th, 2010:

Search and Download over 15 Million Songs directly on your PC using Nexus Radio

{ Posted on Feb 07 2010 by admin }
Categories : Blogging the Tips
Nexus Radio is a free downloadable application that allows users to search for their favorite music, and listen to online radio stations. It allows you to search and listen to over 15 million songs directly on your PC, or connect ...Read More »

Search and Download over 15 Million Songs directly on your PC using Nexus Radio

{ Posted on Feb 07 2010 by admin }
Categories : Blogging the Tips
Nexus Radio is a free downloadable application that allows users to search for their favorite music, and listen to online radio stations. It allows you to search and listen to over 15 million songs directly on your PC, or connect ...Read More »

Search and Download over 15 Million Songs directly on your PC using Nexus Radio

{ Posted on Feb 07 2010 by admin }
Categories : Blogging the Tips
Nexus Radio is a free downloadable application that allows users to search for their favorite music, and listen to online radio stations. It allows you to search and listen to over 15 million songs directly on your PC, or connect ...Read More »

Search and Download over 15 Million Songs directly on your PC using Nexus Radio

{ Posted on Feb 07 2010 by admin }
Categories : Blogging the Tips
Nexus Radio is a free downloadable application that allows users to search for their favorite music, and listen to online radio stations. It allows you to search and listen to over 15 million songs directly on your PC, or connect ...Read More »

GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseases

{ Posted on Feb 07 2010 by admin }
Categories : Health News
GSK announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Over 5,500 rare diseases have been identified(1) of which less than 10% are currently being treated(2), presenting a significant unmet ...Read More »

GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseases

{ Posted on Feb 07 2010 by admin }
Categories : Health News
GSK announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Over 5,500 rare diseases have been identified(1) of which less than 10% are currently being treated(2), presenting a significant unmet ...Read More »

GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseases

{ Posted on Feb 07 2010 by admin }
Categories : Health News
GSK announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Over 5,500 rare diseases have been identified(1) of which less than 10% are currently being treated(2), presenting a significant unmet ...Read More »

GSK Launches New Specialist Unit To Research And Develop Medicines For Rare Diseases

{ Posted on Feb 07 2010 by admin }
Categories : Health News
GSK announces the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Over 5,500 rare diseases have been identified(1) of which less than 10% are currently being treated(2), presenting a significant unmet ...Read More »

ArQule Announces Initiation Of Clinical Programs With ARQ 197 In Germ Cell Tumors And Colorectal Cancer

{ Posted on Feb 07 2010 by admin }
Categories : Health News
ArQule, Inc. (Nasdaq: ARQL) announced the initiation of a Phase 2, single agent trial with ARQ 197 in germ cell tumors (GCT), including testicular and non-central nervous system (non-CNS) tumors, and a Phase 1/2 clinical trial designed to evaluate the ...Read More »

ArQule Announces Initiation Of Clinical Programs With ARQ 197 In Germ Cell Tumors And Colorectal Cancer

{ Posted on Feb 07 2010 by admin }
Categories : Health News
ArQule, Inc. (Nasdaq: ARQL) announced the initiation of a Phase 2, single agent trial with ARQ 197 in germ cell tumors (GCT), including testicular and non-central nervous system (non-CNS) tumors, and a Phase 1/2 clinical trial designed to evaluate the ...Read More »